Coegin Pharma is listed on NGM Nordic SME
The Company’s share capital amounts to SEK 27,566,726.895, divided on 612,593,931 shares, each with a quota value of SEK 0.045. All shares carry the same voting rights and stake in the capital.
Coegin Pharma AB
There are 10,000,000 Series 2020/2024 warrants issued by the Company, 3,000,000 of which have been allotted to key individuals within the company. Each warrant entitles the holder to subscribe for one new share in the company during the period between October 1, 2024, and December 31, 2024, at an exercise price of SEK 0.26 per share. If all warrants are utilized in full, it will entail a dilutive effect of not more than 1.6 percent of the number of shares and votes in the company.
NGM Nordic SME
Nordic SME is a growth market for small and medium-sized enterprises for listing and trading of shares and share-based securities, operated by Nordic Growth Market NGM AB. Nordic SME is a growth market for small and medium-sized enterprises in accordance with MiFID II (Markets in Financial Instruments Directive II). Investors should take into consideration that shares and share-based securities admitted to trading on Nordic SME are not traded on a regulated market and that the company thus is not subject to the same regulations protecting shareholders as a company listed on a regulated market.
114 39 Stockholm, Sweden